A Multicentre Observational Study to Assess Long-term Outcome of Participants in the EXCELLENT Clinical Trial
- First Posted Date
- 2024-07-25
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- CellProthera
- Target Recruit Count
- 48
- Registration Number
- NCT06521047
- Locations
- 🇫🇷
CHU DIJON Hôpital François Mitterrand 14 rue Gaffarel, Dijon, France
🇫🇷Institut Jacques Cartier, Massy, France
🇫🇷Hôpital Haut Levèque, Pessac, France
Donation of Whole Blood by Healthy Volunteers After Mobilisation by Haematopoietic Growth Factor (Rhu-G-CSF = Granocyte)
- First Posted Date
- 2022-10-26
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- CellProthera
- Target Recruit Count
- 40
- Registration Number
- NCT05594433
- Locations
- 🇫🇷
GHU La Pitié-Salpêtrière, Paris, France
🇫🇷CHRU Strasbourg, Strasbourg, France
SINGaporean Program Performed With an eXPANsion Medical Device (SingXpand)
- First Posted Date
- 2019-12-13
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- CellProthera
- Registration Number
- NCT04198883
- Locations
- 🇸🇬
NHCS, Singapore, Singapore
EXCELLENT (EXpanded CELL ENdocardiac Transplantation)
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2016-02-01
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- CellProthera
- Target Recruit Count
- 49
- Registration Number
- NCT02669810
- Locations
- 🇫🇷
CHU BESANCON Hopital Jean Minjoz 3 Boulevard A.Fleming, Besançon, France
🇫🇷Hôpital Haut Levèque, Pessac, France
🇬🇧Ninewells Hospital & Medical School, Dundee, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath